Results 261 to 270 of about 299,295 (343)

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 329-347, February 2026.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla, Stefanie Lip, Hannah O'Neill, Kerry Burke, Vicky Chaplin, Alexander S. F. Doney, Salim Elyas, Nicholas Greaves, Sophie Harding, David Hargroves, Judith Hayward, Dyfrig A. Hughes, Tom A. T. Hughes, Sree Kondapally, Patrick Mok, Aaron Peace, Imran Rafi, Simon Ray, Vicky Stinton, Luigi Venetucci, Munir Pirmohamed   +22 more
wiley   +1 more source

Coronary function testing vs angiography alone to guide treatment of angina with non-obstructive coronary arteries: the ILIAS ANOCA trial. [PDF]

Eur Heart J
Boerhout CKM, Namba HF, Liu T, Beijk MAM, Damman P, Meuwissen M, Ong P, Sechtem U, Appelman Y, Berry C, Escaned J, Lerman A, Henry TD, van der Harst P, Delewi R, Piek JJ, van de Hoef TP.   +16 more
europepmc   +1 more source

EFFECTIVENESS OF AN EDUCATIONAL PROGRAM ON KNOWLEDGE AND ATTITUDES OF ANGINA PATIENTS IN MASHHAD, IRAN: RESULTS OF AN INTERVENTION

, 2007
M R Shidfar, Mostafa Hosseini, Shojaeizadeh Davoud, N Asasi, F Majlesi, Saeid Nazemi   +5 more
openalex   +1 more source

Perbandingan Rasio Neutrofil Terhadap Limfosit pada Pasien Angina Pektoris Stabil, Angina Pektoris Tidak Stabil, dan Infark Miokard Akut Non-Elevasi Segmen St di RSUP Prof. Dr. R. D. Kandou Manado

Teguh Putra Anta Ari, Frans Erwin Nicolaas Wantania, Linda W. A. Rotty   +2 more
openalex   +2 more sources

Chemical Profiling, In Silico and In Vitro Studies to Identify Potential CDK2 and mTOR Inhibitor From Selaginella inaequalifolia (Hook. & Grev.) Spring Ethanolic Extracts

Chemistry &Biodiversity, Volume 23, Issue 2, February 2026.
ABSTRACT The current study is aimed to reveal the phytoprofile of Selaginella inaequalifolia (Hook. & Grev.) Spring using GC–MS and predict the drug properties, toxicity, biological properties of S. inaequalifolia ethanolic extracts (SiEE) using in silico methods and in vitro toxicity assays, namely, MTT and BSLB assay.
Johnson Marimuthu Alias Antonysamy, Sivaraman Arumugam, Robin Charles Antony Arulraj, Anne Wincy Jacob Thomas, Henrique D. M. Coutinho   +4 more
wiley   +1 more source

Supine sleep position and angina frequency: an analysis from the sleep heart health study. [PDF]

Sleep Breath
Logan JG, Byon HD, Lee Y, Kim Y, Park S, Kwon Y.   +5 more
europepmc   +1 more source

Patient‐Specific Lumped‐Parameter Model for Quantifying Vessel‐Specific Remodeling and Predicting Right Ventricular Function in Pulmonary Hypertension

Comprehensive Physiology, Volume 16, Issue 1, February 2026.
Personalized, patient‐specific biophysical model enabling mechanistic assessment of right ventricular (RV) function as well as robust differentiation of pulmonary hypertension (PH) subtype from routine clinical measurements of pulmonary arterial pressure and flow.
Christopher G. Lechuga, Amirreza Kachabi, Mitchel J. Colebank, Claudia E. Korcarz, Farhan Raza, Naomi C. Chesler   +5 more
wiley   +1 more source

The Effectiveness and Safety of Cardiac Shock Wave Therapy in the Treatment of Ischemic Heart Disease with Refractory Angina Pectoris. [PDF]

Vasc Health Risk Manag
Thanh LD, Bien VD, Son PN, Pho DC, Huy PX, Tuan NV, Giang PT.   +6 more
europepmc   +1 more source

Vincent's Angina. [PDF]

, 1918

openalex  

Angina Innocens [PDF]

BMJ, 1937
openaire   +2 more sources